Oragenics News

12 Health Care Stocks Moving In Wednesday's After-Market Session

GainersAnitra (AMEX:AZTR) shares increased by 6.5% to $0.18 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 million. Oragenics (AMEX:OGEN) shares incre

BenzingaJun 5 16:31 ET

12 Health Care Stocks Moving In Wednesday's Intraday Session

GainersIGM Biosciences (NASDAQ:IGMS) shares increased by 36.6% to $11.49 during Wednesday's regular session. The market value of their outstanding shares is at $678.1 million. Akso Health Group (NASDA

BenzingaMay 22 12:31 ET

Express News | Amex Halt Add Info Lst 1.660000

ReutersMay 22 10:08 ET

CureVac, Oragenics, IGM Biosciences Among Healthcare Movers

Seeking AlphaMay 22 10:00 ET

Express News | Amex Halt Add Info Lst 2.520000

ReutersMay 22 09:37 ET

Express News | Oragenics Appoints William “Frank” Peacock Md as Chief Clinical Officer

ReutersMay 22 08:00 ET

Oragenics Appoints William "Frank" Peacock MD as Chief Clinical Officer

Oragenics Appoints William "Frank" Peacock MD as Chief Clinical Officer Download as PDF May 22, 2024Dr. Peacock to Oversee Upcoming Phase II Clinical Trial for Treating Concussion in the Emergency

OragenicsMay 22 00:00 ET

PTC Therapeutics, Oragenics, GT Biopharma Among Healthcare Movers

Seeking AlphaMay 20 10:00 ET

Oragenics OGEN Webinar; Dermata DRMA Warrants Exercise

BioPharmCatalystMay 17 14:34 ET

OGEN, BWEN and SINT Among Mid-day Movers

Seeking AlphaMay 17 14:15 ET

Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine

Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine Download as PDF May 17, 2024SARASOTA, Fla., May 17, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering phar

OragenicsMay 17 00:00 ET

Oragenics to Start Phase 2 Concussion Treatment Drug Trial -- Shares Rise

Oragenics (OGEN) said Thursday that it is preparing to start a phase 2 clinical trial for its potential intranasal treatment for concussion, ONP-002. The company said it has secured an ample supply of

MT NewswiresMay 16 12:52 ET

Express News | Oragenics, Inc. Prepares Intranasal Pharmaceutical, Onp-002, for Phase II Concussion Trial

ReutersMay 16 08:00 ET

Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial

Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial Download as PDF May 16, 2024SARASOTA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE Ameri

OragenicsMay 16 00:00 ET

Oragenics | 10-Q: Quarterly report

SEC announcementMay 15 13:06 ET · Announcements

FFIE, OGEN and CCLD Among Mid-day Movers

Seeking AlphaMay 13 13:30 ET

12 Health Care Stocks Moving In Monday's Intraday Session

GainersCareCloud (NASDAQ:CCLD) stock moved upwards by 80.5% to $2.27 during Monday's regular session. The company's market cap stands at $36.6 million. Novavax (NASDAQ:NVAX) stock rose 42.17% to $12.6

BenzingaMay 13 12:31 ET

Oragenics Inc Reports SEC Filing Update

TipRanksMay 7 13:07 ET

12 Health Care Stocks Moving In Tuesday's Intraday Session

GainersNuwellis (NASDAQ:NUWE) shares rose 57.7% to $0.27 during Tuesday's regular session. The company's market cap stands at $4.1 million. As per the news, the Q1 earnings report came out today. Biov

BenzingaMay 7 12:31 ET

Express News | Oragenics Shares Are Trading Higher After the Company Announced a Partnership With Avance Clinical to Conduct a Phase II Clinical Trial in Australia

BenzingaMay 7 11:56 ET